Comment on Under “right-to-try” law, therapy may go for $300K—with no proof it will work

Under “right-to-try” law, therapy may go for $300K—with no proof it will work

Enlarge (credit: Getty | Bloomberg) A small biotech company called Brainstorm Cell Therapeutics Inc. is among the first companies considering selling an experimental therapy directly to patients under the “right to try” measure, signed into law late last month. And if the company moves forward, it may give its unproven therapy a price tag in the ballpark of $300,000, according to a recent report by Bloomberg, The experimental stem cell-based therapy, called NurOwn, is aimed at treating amyotrophic lateral sclerosis (ALS or Lou Gehrig’s disease).

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News